Group One Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,100
| Closed | -$2.73K | – | 8617 |
|
|
2024
Q4 | $2.73K | Sell |
5,100
-1,000
| -16% | -$697 | ﹤0.01% | 6636 |
|
|
2024
Q3 | $10.7K | Buy |
6,100
+4,300
| +239% | +$6K | ﹤0.01% | 5569 |
|
|
2024
Q2 | $2.11K | Sell |
1,800
-52,100
| -97% | -$130K | ﹤0.01% | 6211 |
|
|
2024
Q1 | $487K | Buy |
53,900
+46,500
| +628% | +$452K | ﹤0.01% | 2754 |
|
|
2023
Q4 | $80.4K | Sell |
7,400
-1,500
| -17% | -$11.2K | ﹤0.01% | 4647 |
|
|
2023
Q3 | $71.6K | Buy |
8,900
+7,700
| +642% | +$64.1K | ﹤0.01% | 4771 |
|
|
2023
Q2 | $13K | Buy |
+1,200
| New | +$10.3K | ﹤0.01% | 6240 |
|
|
2023
Q1 | – | Sell |
-63,800
| Closed | -$254K | – | 8139 |
|
|
2022
Q4 | $254K | Sell |
63,800
-16,900
| -21% | -$83.1K | ﹤0.01% | 3655 |
|
|
2022
Q3 | $537K | Sell |
80,700
-900
| -1% | -$5.54K | ﹤0.01% | 3160 |
|
|
2022
Q2 | $395K | Sell |
81,600
-88,700
| -52% | -$539K | ﹤0.01% | 3646 |
|
|
2022
Q1 | $1.59M | Buy |
170,300
+38,800
| +30% | +$385K | ﹤0.01% | 2626 |
|
|
2021
Q4 | $1.56M | Buy |
131,500
+17,600
| +15% | +$203K | ﹤0.01% | 2870 |
|
|
2021
Q3 | $1.3M | Buy |
113,900
+83,800
| +278% | +$1.15M | ﹤0.01% | 3125 |
|
|
2021
Q2 | $540K | Sell |
30,100
-28,700
| -49% | -$462K | ﹤0.01% | 4139 |
|
|
2021
Q1 | $910K | Sell |
58,800
-374,600
| -86% | -$5.42M | ﹤0.01% | 3351 |
|
|
2020
Q4 | $5.29M | Sell |
433,400
-66,800
| -13% | -$931K | 0.01% | 1232 |
|
|
2020
Q3 | $6.43M | Buy |
500,200
+471,700
| +1,655% | +$4.07M | 0.02% | 758 |
|
|
2020
Q2 | $290K | Buy |
28,500
+1,675
| +6% | +$15.4K | ﹤0.01% | 3080 |
|
|
2020
Q1 | $218K | Sell |
26,825
-8,000
| -23% | -$69.3K | ﹤0.01% | 2683 |
|
|
2019
Q4 | $301K | Sell |
34,825
-3,075
| -8% | -$17.3K | ﹤0.01% | 2866 |
|
|
2019
Q3 | $233K | Sell |
37,900
-2,700
| -7% | -$21.8K | ﹤0.01% | 2976 |
|
|
2019
Q2 | $674K | Sell |
40,600
-52,250
| -56% | -$907K | 0.01% | 1873 |
|
|
2019
Q1 | $1.55M | Buy |
92,850
+12,800
| +16% | +$184K | 0.02% | 1097 |
|
|
2018
Q4 | $919K | Buy |
80,050
+50,675
| +173% | +$1.03M | 0.01% | 1565 |
|
|
2018
Q3 | $1.18M | Buy |
29,375
+11,475
| +64% | +$327K | 0.01% | 1576 |
|
|
2018
Q2 | $506K | Sell |
17,900
-27,825
| -61% | -$617K | ﹤0.01% | 2276 |
|
|
2018
Q1 | $699K | Buy |
45,725
+44,275
| +3,053% | +$1.05M | 0.01% | 1778 |
|
|
2017
Q4 | $47K | Buy |
+1,450
| New | +$39.1K | ﹤0.01% | 3764 |
|
Group One Trading's MRNS Position: Q1 2025 in Review
Group One Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 6,310 shares — an estimated $3.38K sold.
Group One Trading first reported a position in MRNS in Q4 2017 and held it in 27 quarters. The position peaked at $1.36M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Group One Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 6,310 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $3.38K.
- Group One Trading first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 27 quarters.
- Group One Trading's Marinus Pharmaceuticals, Inc position peaked at $1.36M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.